Published in Br J Pharmacol on April 01, 1999
The functional network of ion channels in T lymphocytes. Immunol Rev (2009) 3.21
Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov (2009) 3.12
K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci (2004) 3.12
Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol (2005) 2.08
Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol (2001) 1.85
Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS One (2008) 1.12
The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression. Drug Dev Res (2011) 0.98
The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker. PLoS One (2012) 0.82
Use of Kv1.3 blockers for inflammatory skin conditions. Curr Med Chem (2010) 0.80
State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine. Br J Pharmacol (2015) 0.76
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840. Expert Opin Ther Pat (2010) 0.76
Kv1.1 channelopathy abolishes presynaptic spike width modulation by subthreshold somatic depolarization. Proc Natl Acad Sci U S A (2017) 0.75
Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Receptors Channels (1993) 8.09
Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain. EMBO J (1989) 5.66
Dynamic rearrangement of the outer mouth of a K+ channel during gating. Neuron (1996) 5.52
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature (1984) 4.70
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol (1994) 4.24
A voltage-gated potassium channel in human T lymphocytes. J Physiol (1985) 4.16
C-type inactivation of a voltage-gated K+ channel occurs by a cooperative mechanism. Biophys J (1995) 2.97
Cooperative subunit interactions in C-type inactivation of K channels. Biophys J (1995) 2.84
TEA prevents inactivation while blocking open K+ channels in human T lymphocytes. Biophys J (1989) 2.82
Potassium and calcium channels in lymphocytes. Annu Rev Immunol (1995) 2.68
Cloned neuronal IK(A) channels reopen during recovery from inactivation. Nature (1991) 2.65
Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med (1984) 2.54
Recovery from C-type inactivation is modulated by extracellular potassium. Biophys J (1996) 2.52
Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry (1994) 2.51
ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem (1998) 1.87
Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc Natl Acad Sci U S A (1990) 1.85
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins. Neuron (1995) 1.70
Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes. J Gen Physiol (1989) 1.69
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med (1993) 1.67
Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci U S A (1992) 1.65
Divalent ion trapping inside potassium channels of human T lymphocytes. J Gen Physiol (1989) 1.53
Current inactivation involves a histidine residue in the pore of the rat lymphocyte potassium channel RGK5. Biochem Biophys Res Commun (1991) 1.49
Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1989) 1.44
Evidence for voltage modulation of IL-2 production in mitogen-stimulated human peripheral blood lymphocytes. J Immunol (1992) 1.32
Subunit combinations defined for K+ channel Kv1 subtypes in synaptic membranes from bovine brain. Biochemistry (1997) 1.27
Regulation of mammalian Shaker-related K+ channels: evidence for non-conducting closed and non-conducting inactivated states. J Physiol (1998) 1.23
Ion channels in the immune system as targets for immunosuppression. Curr Opin Biotechnol (1997) 1.22
Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation. Mol Pharmacol (1996) 1.18
Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345. Nature (1993) 1.16
Subunit composition of brain voltage-gated potassium channels determined by hongotoxin-1, a novel peptide derived from Centruroides limbatus venom. J Biol Chem (1998) 1.15
Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3. Mol Pharmacol (1996) 1.13
The signature sequence of voltage-gated potassium channels projects into the external vestibule. J Biol Chem (1996) 1.13
Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes. Evidence for association with the voltage-gated K+ channel. J Biol Chem (1991) 1.12
T cell activation is regulated by voltage-dependent and calcium-activated potassium channels. J Immunol (1996) 1.03
Purification, visualization, and biophysical characterization of Kv1.3 tetramers. J Biol Chem (1997) 1.03
Heterologous expression of the human potassium channel Kv2.1 in clonal mammalian cells by direct cytoplasmic microinjection of cRNA. Pflugers Arch (1992) 0.96
The P-region and S6 of Kv3.1 contribute to the formation of the ion conduction pathway. Biophys J (1994) 0.96
Three new toxins from the scorpion Pandinus imperator selectively block certain voltage-gated K+ channels. Mol Pharmacol (1996) 0.93
Characterization of the transcription unit of mouse Kv1.4, a voltage-gated potassium channel gene. J Biol Chem (1996) 0.91
Cloned T-cell proliferation and synthesis of specific proteins are inhibited by quinine. Proc Natl Acad Sci U S A (1986) 0.87
WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes. Mol Pharmacol (1995) 0.80
Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol Biol Evol (1987) 15.79
Construction and properties of an integrable plasmid for Bacillus subtilis. J Bacteriol (1983) 7.12
Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science (1999) 5.22
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature (1984) 4.70
Mitogen-induced oscillations of cytosolic Ca2+ and transmembrane Ca2+ current in human leukemic T cells. Cell Regul (1989) 4.28
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol (1994) 4.24
A voltage-gated potassium channel in human T lymphocytes. J Physiol (1985) 4.16
Local anesthetic block of sodium channels in normal and pronase-treated squid giant axons. Biophys J (1978) 4.08
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A (2000) 4.01
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology (2006) 3.93
High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12. Nucleic Acids Res (1987) 3.52
Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma (1982) 3.36
Polarity of T cell shape, motility, and sensitivity to antigen. Immunity (1996) 3.33
Sodium channel permeation in squid axons. I: Reversal potential experiments. J Physiol (1980) 3.08
Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem (2000) 2.85
Interactions between quaternary lidocaine, the sodium channel gates, and tetrodotoxin. Biophys J (1979) 2.77
A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol Sci (1999) 2.71
Potassium and calcium channels in lymphocytes. Annu Rev Immunol (1995) 2.68
Lymphoid tissue architecture. Experimental analysis of the origin and distribution of T-cells and B-cells. Immunology (1972) 2.65
Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U S A (2001) 2.63
Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med (1984) 2.54
Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci U S A (1994) 2.42
Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41
Conductance and permeation of monovalent cations through depletion-activated Ca2+ channels (ICRAC) in Jurkat T cells. Biophys J (1996) 2.36
Block of sodium conductance and gating current in squid giant axons poisoned with quaternary strychnine. Biophys J (1979) 2.30
Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J Cell Biol (2000) 2.26
Modification of sodium channel gating in frog myelinated nerve fibres by Centruroides sculpturatus scorpion venom. J Physiol (1975) 2.19
Sodium channel permeation in squid axons. II: Non-independence and current-voltage relations. J Physiol (1980) 2.10
Chloride channels activated by osmotic stress in T lymphocytes. J Gen Physiol (1993) 1.99
Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology. J Gen Physiol (1993) 1.93
Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J Biol Chem (2001) 1.88
ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem (1998) 1.87
Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci U S A (1995) 1.85
Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol (2001) 1.85
Molecular evolution of voltage-sensitive ion channel genes: on the origins of electrical excitability. Mol Biol Evol (1993) 1.85
Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc Natl Acad Sci U S A (1990) 1.85
Systemic inflammatory response syndrome, organ failure, and outcome in critically ill obstetric patients treated in an ICU. Chest (2001) 1.83
Subset-specific expression of potassium channels in developing murine T lymphocytes. Science (1988) 1.80
Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J Biol Chem (1999) 1.78
[Partial uterine wall necrosis following Cho hemostatic sutures for the treatment of postpartum hemorrhage]. Gynecol Obstet Fertil (2009) 1.76
Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis. Proc Natl Acad Sci U S A (1987) 1.72
Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins. Neuron (1995) 1.70
Allelic forms of rat kappa chain genes: evidence for strong selection at the level of nucleotide sequence. Proc Natl Acad Sci U S A (1981) 1.70
Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes. J Gen Physiol (1989) 1.69
Ca(2+)-activated K+ channels in human leukemic T cells. J Gen Physiol (1992) 1.66
JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc Natl Acad Sci U S A (1999) 1.65
Homing properties of thymus-independent follicular lymphocytes. Transplantation (1973) 1.64
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Br J Pharmacol (2010) 1.59
Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol (1999) 1.59
DMSA study performed during febrile urinary tract infection: a predictor of patient outcome? Eur J Nucl Med Mol Imaging (2004) 1.55
Single-channel recording of a store-operated Ca2+ channel in Jurkat T lymphocytes. Science (1999) 1.55
Single channel properties and regulated expression of Ca(2+) release-activated Ca(2+) (CRAC) channels in human T cells. J Cell Biol (2000) 1.54
Divalent ion trapping inside potassium channels of human T lymphocytes. J Gen Physiol (1989) 1.53
[Hepatic resections. Analysis of data from the Tumor Documentation Center in the state of Brandenburg, Germany, focusing on liver metastases of colorectal carcinoma]. Chirurg (2006) 1.50
Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1. J Biol Chem (2001) 1.50
Calcium oscillations in human T and natural killer cells depend upon membrane potential and calcium influx. J Immunol (1993) 1.49
Two types of potassium channels in murine T lymphocytes. J Gen Physiol (1987) 1.48
Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations. J Virol (1986) 1.47
Mitogen induction of ion channels in murine T lymphocytes. J Gen Physiol (1987) 1.47
Human homologue of the Drosophila discs large tumor suppressor binds to p56lck tyrosine kinase and Shaker type Kv1.3 potassium channel in T lymphocytes. J Biol Chem (1997) 1.46
Simplified gene nomenclature. Nature (1991) 1.44
A family of three mouse potassium channel genes with intronless coding regions. Science (1990) 1.43
Ca2+ influx pathways mediated by swelling or stores depletion in mouse thymocytes. J Gen Physiol (1995) 1.42
Substantial outgassing of CO from comet Hale-Bopp at large heliocentric distance. Nature (1996) 1.38
Voltage-dependent ion channels in T-lymphocytes. J Neuroimmunol (1985) 1.36
The star-allele nomenclature: retooling for translational genomics. Clin Pharmacol Ther (2007) 1.35
Phosphorylation of serine-15 of maize leaf sucrose synthase. Occurrence in vivo and possible regulatory significance. Plant Physiol (1996) 1.34
Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin. J Biol Chem (1999) 1.33
Differential Ca2+ influx, KCa channel activity, and Ca2+ clearance distinguish Th1 and Th2 lymphocytes. J Immunol (2000) 1.32
Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol (1991) 1.31